ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: MB Withdraws From Fight Over Funding New Constructions, Tosses The Ball To Ted Cooper

January 9, 1976

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

Neulasta Reduces Incidence Of Febrile Neutropenia

February 22, 2013

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

NCI Commits $8 Million More to R01s, Increases Payline to 12th Percentile. Surgeon General’s Report Says There’s No Safe Level of Secondhand Smoke.

June 30, 2006

House Members Express Support for Cancer Program

September 12, 1980